Press Release (ePRNews.com) - Miami, FL - Oct 03, 2016 - Guillaume Corpart—Managing Director of Global Health Intelligence, the leading healthcare data analytics provider in Latin America—will be speaking at Dispositivos Médicos América Latina 2016. This annual event brings together the industry leaders of the medical devices market in LatAm and takes place Oct 3-4 in Mexico City, Mexico.
Corpart’s presentation combines an overview of the Latin American healthcare market while offering key insights into the region’s growth potential for medical devices. His analysis will also break down crucial market trends and offer attendees insights for increasing their market share via strategic sales modeling.
“We’re excited to attend the Dispositivos Médicos event because of the opportunities to share insights with LatAm healthcare industry leaders. It’s also helpful for us to learn about the challenges that face healthcare professionals in Latin America so we can further expand our market intelligence offerings to give them the data they need to make well-informed decisions,” says Corpart.
We’re excited to attend the Dispositivos Médicos event because of the opportunities to share insights with LatAm healthcare industry leaders. It’s also helpful for us to learn about the challenges that face healthcare professionals in Latin America.
Despite this being only the second year for Dispositivos Médicos América Latina, the event will feature the major healthcare and biomedical firms active in the region, including Medtronic, Siemens, GE Healthcare, Olympus América, J&J Medical Devices, Baxter and more.
About Global Health Intelligence
Global Health Intelligence has the world’s largest hospital demographics database focused on Latin America, with data on 8 out of every 10 hospitals in the region across 11 countries. The firm updates more than 2 million hospital data points each year, helping clients with custom research, data on the medical devices market, competitive profiling for the LatAm healthcare industry, marketing sizing, segmentation and pricing/cost analyses. Source :
Global Health Intelligence